packageCatridecacog

catridecacog

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Catridecacog is a recombinant coagulation factor XIII A-subunit used to treat inherited blood coagulation disorders, specifically factor XIII deficiency. It is approved and authorised in the European Union, though it is a specialised product used in a small patient population.

Summary written by glm-5.3-flash from Wikidata Q16858452 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:catridecacog
ATC codes:B02BD11
DrugBank:DB09310
Wikidata:Q16858452

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown